KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $25,000 | -68.4% | 114,308 | -56.3% | 0.00% | – |
| Q2 2022 | $79,000 | -95.3% | 261,744 | -78.6% | 0.00% | – |
| Q1 2022 | $1,690,000 | +25.1% | 1,224,965 | +9.7% | 0.00% | – |
| Q4 2021 | $1,351,000 | -53.6% | 1,116,291 | +0.4% | 0.00% | – |
| Q3 2021 | $2,913,000 | -33.2% | 1,111,688 | +35.2% | 0.00% | – |
| Q2 2021 | $4,358,000 | -7.6% | 822,294 | +17.5% | 0.00% | – |
| Q1 2021 | $4,716,000 | -3.1% | 699,746 | -2.5% | 0.00% | – |
| Q4 2020 | $4,867,000 | -12.4% | 717,778 | -3.1% | 0.00% | – |
| Q3 2020 | $5,556,000 | -28.8% | 740,754 | -0.2% | 0.00% | -100.0% |
| Q2 2020 | $7,803,000 | +107.2% | 742,394 | +73.3% | 0.00% | – |
| Q1 2020 | $3,766,000 | +181.3% | 428,414 | +18.1% | 0.00% | – |
| Q4 2019 | $1,339,000 | +9.0% | 362,838 | +12.5% | 0.00% | – |
| Q3 2019 | $1,228,000 | -27.6% | 322,639 | +21.4% | 0.00% | – |
| Q2 2019 | $1,696,000 | -7.9% | 265,855 | +19.4% | 0.00% | – |
| Q1 2019 | $1,841,000 | +85.4% | 222,566 | +9.6% | 0.00% | – |
| Q4 2018 | $993,000 | -48.5% | 203,014 | +3.8% | 0.00% | – |
| Q3 2018 | $1,929,000 | -27.1% | 195,643 | +1.5% | 0.00% | – |
| Q2 2018 | $2,647,000 | -17.6% | 192,795 | -5.0% | 0.00% | – |
| Q1 2018 | $3,213,000 | +107.4% | 202,895 | +142.6% | 0.00% | – |
| Q4 2017 | $1,549,000 | +20.5% | 83,634 | +48.5% | 0.00% | – |
| Q3 2017 | $1,286,000 | – | 56,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |